Lisa Bright
2020
Compensation breakdown
| Non-Equity Incentive Plan | $240,955 |
|---|---|
| Option Awards | $453,467 |
| Salary | $480,552 |
| Stock Awards | $925,704 |
| Other | $139,106 |
| Total | $2,239,784 |
Bright received $925.7K in stock awards, accounting for 41% of the total pay in 2020.
Bright also received $241K in non-equity incentive plan, $453.5K in option awards, $480.6K in salary and $139.1K in other compensation.
Rankings
In 2020, Lisa Bright's compensation ranked 5,015th out of 13,090 executives tracked by ExecPay. In other words, Bright earned more than 61.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,015 out of 13,090 | 62nd |
Division Manufacturing | 2,044 out of 5,621 | 64th |
Major group Chemicals And Allied Products | 814 out of 2,254 | 64th |
Industry group Drugs | 703 out of 1,954 | 64th |
Industry Pharmaceutical Preparations | 528 out of 1,459 | 64th |
Pay ratio
| Lisa Bright's Pay | $2,239,784 |
|---|---|
| Median Employee's Pay | $267,493 |
| Pay Ratio | 8to 1 |
In 2020, the annual total compensation of Lisa Bright was $2,239,784.
The annual total compensation of the median employee at Intercept Pharmaceuticals was $267,493.
The ratio of Lisa Bright's pay to the pay of median employee was therefore 8 to one.
Bright's colleagues
We found six more compensation records of executives who worked with Lisa Bright at Intercept Pharmaceuticals in 2020.
2020
Mark Pruzanski
Intercept Pharmaceuticals
Chief Executive Officer
2020
Jerome Durso
Intercept Pharmaceuticals
Chief Operating Officer
2020
Sandip Kapadia
Intercept Pharmaceuticals
Chief Financial Officer
2020
Richard Kim
Intercept Pharmaceuticals
Former President, U.S. Commercial & Strategic Marketing
2020
Ryan Sullivan
Intercept Pharmaceuticals
General Counsel
2020
Christian MAS
Intercept Pharmaceuticals